Log in to search using one of your social media accounts:

 

mesalamine (Pentasa, Rowasa, SfRowasa, Lialda, Canasa, Apriso, Delzicol)
Title: mesalamine (Pentasa, Rowasa, SfRowasa, Lialda, Canasa, Apriso, Delzicol)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/17/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 17, 2017 Category: Drugs & Pharmacology Source Type: news

Delzicol (Mesalamine Delayed-Release Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 7, 2017 Category: Drugs & Pharmacology Source Type: news

Asacol HD (Mesalamine Delayed-Release Tablets, Oral) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 3, 2017 Category: Drugs & Pharmacology Source Type: news

Zydus Cadila gets USFDA nod for its ulcerative colitis drug
The company has received final approval from the USFDA for Mesalamine delayed-release tablets in the strength of 800 mg, Zydus Cadila said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 25, 2017 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for mesalamine tablets
Zydus Cadila was the first to file an Abbreviated New Drug Application (ANDA) for the generic version of Lialda (mesalamine), the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 7, 2017 Category: Pharmaceuticals Source Type: news

mesalamine, Lialda
Title: mesalamine, LialdaCategory: MedicationsCreated: 12/10/2008 12:00:00 AMLast Editorial Review: 5/12/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 12, 2017 Category: Nutrition Source Type: news

mesalamine, Pentasa, Rowasa, Asacol HD, Lialda, Canasa, Apriso, Delzicol
Title: mesalamine, Pentasa, Rowasa, Asacol HD, Lialda, Canasa, Apriso, DelzicolCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/11/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 11, 2017 Category: Nutrition Source Type: news

Mesalamine Enemas May Be Helpful in Pediatric Ulcerative Colitis Mesalamine Enemas May Be Helpful in Pediatric Ulcerative Colitis
Following failure of high-dose oral mesalamine (5-aminosalicylic acid), topical enemas containing the agent may be effective in many children with mild to moderate ulcerative colitis (UC), according to Israeli and Finnish researchers.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 20, 2017 Category: Surgery Tags: Pediatrics News Source Type: news

Budesonide Multi-matrix Induces Endoscopic Remission in Refractory UC Budesonide Multi-matrix Induces Endoscopic Remission in Refractory UC
Budesonide multi-matrix induces remission in patients with mild to moderate mesalamine-refractory ulcerative colitis (UC), researchers report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 24, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news

Rowasa (Mesalamine Rectal Suspension Enema) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 24, 2017 Category: Drugs & Pharmacology Source Type: news

U-M researchers discover what makes drug for ulcerative colitis tick
(University of Michigan) For approximately 70 years, physicians have used a medication containing the active agent mesalamine to treat ulcerative colitis, but little was known about how the drug targeted the inflammatory bowel disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 23, 2017 Category: Global & Universal Source Type: news

Lialda (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 18, 2017 Category: Drugs & Pharmacology Source Type: news

Pentasa (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 13, 2017 Category: Drugs & Pharmacology Source Type: news

Asacol (Mesalamine Delayed-Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 13, 2017 Category: Drugs & Pharmacology Source Type: news

Apriso (Mesalamine Extended-Release Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 3, 2017 Category: Drugs & Pharmacology Source Type: news

Canasa (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 16, 2016 Category: Drugs & Pharmacology Source Type: news

Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
DUBLIN, Dec. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, and its subsidiaries today announced that they, along with Qualicaps Co., Ltd., have reached a settlement regarding their litiga... Biopharmaceuticals, Litigation Allergan, Zydus Pharmaceuticals, DELZICOL, mesalamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 2, 2016 Category: Pharmaceuticals Source Type: news

Pharma ’s Nutritional Value
With previous senior management roles at both Novartis and Boehringer Ingelheim, Greg Behar is a pharma man – or he was. In 2014, he became CEO ofNestl é Health Science, a company whose mission is to place nutrition into a key role in the management of people ’s health.While Nestl é itself is best-known as a manufacturer of confectionary, Nestlé Health Science occupies the space between nutrition and pharma – science-based, personalized nutritional therapies. Behar, who will be speaking ateyeforpharma Barcelona 2017, says the company offers great opportunities to develop “amazin...
Source: EyeForPharma - October 4, 2016 Category: Pharmaceuticals Authors: Adam Hill Source Type: news

Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
LIALDA Patent Upheld and Extends through June 8, 2020 LEXINGTON, Massachusetts, March 29, 2016 -- (Healthcare Sales & Marketing Network) -- Shire plc (LSE: SHP, NASDAQ: SHPG) and its subsidiary, Shire Development LLC, announced today that the United St... Biopharmaceuticals, Generics, LitigationShire plc, LIALDA, mesalamine, Watson Pharmaceuticals, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2016 Category: Pharmaceuticals Source Type: news

Shire gets favorable ruling against Allergan in Lialda patent case
(Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020. (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

mesalamine, Lialda
Title: mesalamine, LialdaCategory: MedicationsCreated: 12/10/2008 12:00:00 AMLast Editorial Review: 1/22/2016 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 22, 2016 Category: Nutrition Source Type: news

Anti-TNF Best at Preventing Postsurgery Relapse in Crohn's Anti-TNF Best at Preventing Postsurgery Relapse in Crohn's
Anti-TNF appears to be more effective than mesalamine, antibiotics, and budesonide. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 6, 2015 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

mesalamine, Pentasa, Rowasa, Asacol, Asacol HD, Lialda, Canasa, Apriso, Delzicol
Title: mesalamine, Pentasa, Rowasa, Asacol, Asacol HD, Lialda, Canasa, Apriso, DelzicolCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/1/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 1, 2014 Category: Drugs & Pharmacology Source Type: news

mesalamine, Pentasa, Rowasa, Asacol, Asacol HD, Lialda, Canasa, Apriso, Delzicol
Title: mesalamine, Pentasa, Rowasa, Asacol, Asacol HD, Lialda, Canasa, Apriso, DelzicolCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/1/2014 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 1, 2014 Category: Nutrition Source Type: news

Cadila Healthcare inks pact with Warner Chilcott to settle patent dispute
Cadila Healthcare along with Zydus Pharmaceuticals have entered into an agreement with Warner Chilcott Company to settle all outstanding patent litigation related to Asacol HD. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2013 Category: Pharmaceuticals Source Type: news

Pentasa (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 9, 2013 Category: Drugs & Pharmacology Source Type: news

Mesalamine Suppositories Helpful in Ulcerative ColitisMesalamine Suppositories Helpful in Ulcerative Colitis
Mesalamine (mesalazine) suppositories are significantly more effective than placebo for rectal inflammation in patients with ulcerative colitis (UC), Japanese researchers say. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 25, 2013 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Canasa (Mesalamine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 26, 2013 Category: Drugs & Pharmacology Source Type: news

Delzicol (Mesalamine Delayed-Release Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 19, 2013 Category: Drugs & Pharmacology Source Type: news

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol
DUBLIN, Ireland, Feb. 5, 2013 -- Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the treatment of ulcerative colitis. The product will be... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 6, 2013 Category: Drugs & Pharmacology Source Type: news

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product
DUBLIN, Ireland, Feb. 5, 2013 -- (Healthcare Sales & Marketing Network) -- Warner Chilcott plc (WCRX) today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the treatment of ul... Biopharmaceuticals, Gastroenterology, FDAWarner Chilcott, DELZICOL, mesalamine, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2013 Category: Pharmaceuticals Source Type: news

Simple urine test picks up mesalamine non-adherence
A readily available urine test could identify ulcerative colitis patients who are non-adherent to their mesalamine therapy, research shows. (Source: MedWire News - Gastroenterology)
Source: MedWire News - Gastroenterology - January 24, 2013 Category: Gastroenterology Source Type: news